| Pharmaceutical active ingredients: |
| Ergoloid Mesylates |
| Available forms, composition and doses of Hydergina: |
| Injectable; Injection; Ergoloid MesylatesSolution; Oral; Ergoloid Mesylates 5 mg / 5 mlTablets, Film-Coated; Oral; Ergoloid Mesylates |
| Hydergina medical category: |
| Human:Sympatholytic (adrenergic blocking) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C04AE01 - Ergoloid Mesylates |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |